DENGUE VACCINES MARKET ANALYSIS

Market Challenges And Opportunities

Global Dengue Vaccine Market: Restraints

Inability to distinguish dengue fever from other febrile diseases is expected to hinder growth of the market. For instance, the symptoms of mosquito-borne diseases such as Zika, chikungunya virus infection, and dengue fever are very similar, which makes the diagnosis difficult.

Moreover, lack of understanding of the pathophysiology of dengue infection and the lack of specific animal models is expected to hinder growth of the market.

Global Dengue Vaccine Market: Opportunities 

Increasing incidents of dengue in urban areas is expected to offer lucrative growth opportunities for players in the market. For instance, in July 2018, researchers from Center for Information Technology, Bruno Kessler Foundation, Italy, reported that spread of dengue in a non-endemic Brazilian metropolis was similar to a large dengue epidemic in Cairns, Australia, where 95% of transmission events were localized within the city.

Shifts in the age patterns of dengue is also expected to boost growth of the market. For instance, in February 2018, researchers at Taipei Medical University reported that dengue infection rate increases with age and the female population exhibited a higher infection rate if they were older than 40 years.